Products
15271 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nokia Constant Leverage with ISIN code: CH1450970210 | Nokia | Constant Leverage | Long | ― | 5.507 | 3.41 | 0.070 | 3.48 | 1 | -2.01% | 32.17% | 56.42% | 3 Nov. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 5.507 | 1.34 | 0.030 | 1.37 | 1 | -2.19% | 13.56% | 26.42% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 5.507 | 43.64 | 0.930 | 44.57 | 1 | -2.09% | 31.88% | 56.42% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 5.507 | 0.074 | 0.003 | 0.077 | 1 | -3.90% | -26.00% | -50.67% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 5.507 | 0.088 | 0.003 | 0.091 | 1 | -3.30% | -20.00% | -37.14% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 108.333 | 15.49 | ― | ― | 1 | 0.00% | 29.95% | 58.22% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 108.333 | 12.03 | ― | ― | 1 | 0.00% | 9.46% | 18.76% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 108.333 | 1.03 | ― | ― | 1 | 0.00% | 22.62% | 45.07% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 108.333 | 7.92 | ― | ― | 1 | 0.00% | 14.62% | 28.57% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 108.333 | 3.56 | ― | ― | 1 | 0.00% | 19.06% | 37.45% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 108.333 | 0.33 | ― | ― | 1 | 0.00% | -21.43% | -34.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 108.333 | 1.38 | ― | ― | 1 | 0.00% | -12.10% | -21.14% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 108.333 | 0.21 | ― | ― | 1 | 0.00% | -34.38% | -54.35% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 108.333 | 0.068 | ― | ― | 1 | 0.00% | -20.93% | -38.18% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 108.333 | 0.48 | ― | ― | 1 | 0.00% | -28.36% | -47.25% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 306.975 | 0.088 | 0.003 | 0.091 | 1 | -3.30% | -41.33% | -92.07% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 306.975 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 306.975 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 306.975 | 2.15 | 0.040 | 2.19 | 1 | -1.83% | -24.83% | -24.30% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 306.975 | 5.03 | 0.060 | 5.09 | 1 | -1.18% | -17.00% | -11.75% | 21 Aug. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.